“…Nonetheless, prostaglandins were implicated in both the mechanism by which the flush develops [10] and the aetiology of both small and large blood vessel disease in diabetic patients [19], by reasoning similar to that underlying the previous announcement of 'Sensitivity to enkephalin as a cause of Type 2 diabetes' [8], still promoted 3 years later [49]. The blockade of CPAF by naloxone [8] indicated the complexity of the underlying mechanism, as well as providing a lead to disclosing the combination of chlorpropamide and alcohol as the first known stimulus increasing plasma met-enkephalin [13], in both flushers and non-flushers.…”